← Human Trials & Peer-Reviewed Studies
The prevalence of isolated growth hormone deficiency among children of short stature in Jordan and its relationship with consanguinity.
Plain-language guide to PMID 25041402 (2014): observational study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 50 boys.
Key Facts
- PMID
- 25041402
- Journal
- Clinical endocrinology
- Year
- 2014
- Study type
- Observational Study
- Authors
- Zayed AA et al. (5 authors)
- DOI
- 10.1111/cen.12510
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as an observational study.
The prevalence of isolated growth hormone deficiency (IGHD) among short-statured children in Jordan, where consanguineous marriage (CM) is common, is unknown.
No studies have investigated the relationship between degrees of consanguinity and IGHD.
This study aimed to determine the prevalence of IGHD among short-statured children referred to a university hospital in Jordan and its relationship with different degrees of consanguinity.
Who Took Part
The abstract describes 50 boys taking part.
By PubMed's age tags, the people studied were children and teenagers, both men and women.
The researchers conducted a 24-month cross-sectional observational trial at an outpatient tertiary care center in Amman, Jordan.
The researchers obtained detailed family histories, medical evaluations and laboratory tests for 94 short-statured children (50 boys and 44 girls aged 6-16 years).
What Was Measured
The subject headings attached to it are Consanguinity, Cross-Sectional Studies, Dwarfism, Pituitary, Growth Disorders, Jordan, Prevalence and Tertiary Care Centers.
What This Means in Plain Language
This is an observational study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 50 boys.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2014 (Clinical endocrinology), a journal based in England.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.